Atossa Therapeutics, Inc.
ATOS
$0.7775
$0.03354.50%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -8.42M | -6.72M | -6.35M | -7.23M | -6.05M |
Total Depreciation and Amortization | 4.00K | 4.00K | 4.00K | 4.00K | 4.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 796.00K | 563.00K | 778.00K | 2.46M | 354.00K |
Change in Net Operating Assets | 364.00K | 192.00K | -1.49M | 18.00K | 1.16M |
Cash from Operations | -7.26M | -5.96M | -7.05M | -4.75M | -4.53M |
Capital Expenditure | 0.00 | -9.00K | 0.00 | -10.00K | -3.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 0.00 | -9.00K | 0.00 | -10.00K | -3.00K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | 3.37M | 0.00 | 100.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -- | 3.37M | 0.00 | 100.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -7.26M | -5.97M | -3.68M | -4.76M | -4.43M |